Prognostic significance of GLUT-1 and p-Src expression in Mucoepidermoid carcinoma

Document Type : Original Article

Authors

1 Associate Professor of Oral Pathology, Faculty of Dentistry, Mansoura University; Associate Professor of Oral Pathology, Faculty of Dentistry, Horus University, Egypt.

2 Associate Professor of Oral Biology, Faculty of Dentistry, Mansoura University; Associate Professor of Oral Biology, Faculty of Dentistry, Horus University, Egypt.

Abstract

Background and objective: Mucoepidermoid carcinoma (MEC) includes a variety of clinical, biological, and histological forms, all of which pose difficulties and challenges in terms of diagnosis, grading, and treatment. Glucose transporter protein 1 (GLUT-1) is involved in the glycolysis of tumor cells. This protein's high expression in malignant neoplasms is linked to tumor aggressiveness. P-Src belongs to a family of cytoplasmic tyrosine kinases and plays a role in tumor initiation and progression. The study aims to predict the aggressiveness of different grades of MEC through studying the expression of GLUT-1 and p-Src in five years of follow-up.
Materials and methods: Thirty paraffin blocks, included MEC from the pathology laboratory of the Oncology Center Mansoura University were preceded for post-operative follow-up for at least five years. Hematoxylin and eosin stained sections, tumors were scored and graded according to WHO grading system 4th edition. Disease-free survival (DFS) and overall survival (OS) were determined for each case. Immunohistochemical staining for the rabbit polyclonal antibody anti-GLUT-1 and the rabbit polyclonal antibody anti p-Src were performed using a Dako Autostainer with a Universal Staining System.
Results: A statistically significant correlation between GLUT-1 and p-Src expression with tumor grades, DFS, and OS. Direct correlation between GLUT-1 and p-Src expression regarding tumor grades, the living and dead status of the cases, recurrence, DFS, and OS.
Conclusion: GLUT-1 and p-Src might serve as good prognostic markers for MEC as their expression is associated with tumor grades, DFS and OS, they might be considered promising therapeutic targets for MEC.

Keywords

Main Subjects